Stock listing

MGTX Stock Price, News, Filings & Events — Meiragtx Holdings Plc

Selected listing: MGTX · NASDAQ · USD · US

This page tracks Meiragtx Holdings Plc's MGTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MGTX:NASDAQ. MGTX:NASDAQ is the stock-level entry point for investors researching Meiragtx Holdings Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Meiragtx Holdings Plc is a public company traded under the ticker MGTX in the American market. With a market capitalization of approximately $1.09 billion, the company focuses on developing innovative gene therapies. Meiragtx aims to address unmet medical needs through its advanced research and development efforts.

MGTX:NASDAQUSDUSUpdated September 11, 2026
Meiragtx Holdings Plc logo
Ticker
MGTX:NASDAQ
Asset type
Stock
Market cap
$1.23B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Meiragtx Holdings Plc MGTX:NASDAQ stock context

This page tracks Meiragtx Holdings Plc's MGTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MGTX:NASDAQ. MGTX:NASDAQ is the stock-level entry point for investors researching Meiragtx Holdings Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Meiragtx Holdings Plc is a public company traded under the ticker MGTX in the American market. With a market capitalization of approximately $1.09 billion, the company focuses on developing innovative gene therapies. Meiragtx aims to address unmet medical needs through its advanced research and development efforts.

Latest news from Meiragtx Holdings Plc

All Meiragtx Holdings Plc news →

Research Meiragtx Holdings Plc

Alternate listings